Amerpharmasp. z o.o.

Manufacture of homogenised food preparations and dietetic food

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2019-12-31
Share capital
60 000,00 PLN
Activity description

Amerpharma provides private-label and white-label production of dietary supplements and functional food, including custom formulation, product development, contract manufacturing and liquid bottling. Its products include electrolyte concentrates, energy gels, zero-calorie syrups and matcha products; the company states it has 15 years of experience and more than 150 brand launches.

Registered address
ul. Makowa 6 B, 20-442 Lublin, Poland
Website
amerpharma.comWebsite active
Phone
Social media
Electronic delivery address
AE:PL-21652-98888-TIISW-08

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 7.19mMedianUSD 426.41kAverageUSD 6.29m
Net profit
This companyUSD 526.27kMedianUSD 7.02kAverageUSD 456.45k
Operating costs
This companyUSD 6.26mMedianUSD 402.63kAverageUSD 5.58m
Assets
This companyUSD 8.22mMedianUSD 378.64kAverageUSD 5.67m

Bank accounts

Registered as a VAT taxpayer on 2019-12-31. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

19 public aid cases recorded, with a total value of $361,216.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
–
De minimis aid (in accordance with Commission Regulation 2023/2831)
–
De minimis aid (in accordance with Commission Regulation 2023/2831)
–

European Funds

6 projects co-financed from European Funds recorded, with total EU co-financing of $507,431.

ProjectEU co-financing
Przygotowanie do internacjonalizacji przedsiębiorstwa AmerPharma Sp. z o.o na nowe rynki zagraniczne.
$35,460
Wypromowanie marki AMERPHARMA na rynkach Zatoki Perskiej.
$28,047
Promocja marki i produktów Klement Real Estate na wybranych rynkach zagranicznych w celu zdobycia nowych rynków zbytu
$21,001

Tenders

No recorded participation in tenders.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Johan Lennartsson – Management Board Member
Mariusz Stanisław Klementowski – President of the Management Board

Manner of representation

If the management board is a one-person management board, the sole member of the management board has the right to represent the company. If the management board consists of two members, the President of the Management Board represents the company independently, while the member of the management board may do so only jointly with the President of the Management Board.

Ownership

OwnerSharesShare valueStake
588$7,941.6532.8859%
Humble Group Ab
612$8,265.8034.2282%
588$7,941.6532.8859%

Beneficial owners

Person

Subsidiaries

NameStake
Drnutssp. z o.o.
50%

Competitors

Name
ALG Pharmasp. z o.o.
Laboratoria Naturysp. z o.o.
Natural Brandssp. z o.o.
Prowanasp. z o.o.
Norsa Pharmasp. z o.o.
Mipama E.Z.Szafarzsp. j.
Gofarmsp. z o.o. + limited partnership
Puwer Polskasp. z o.o.
INV Polandsp. z o.o.
Supplelabsp. z o.o. + limited partnership

Change history

DateEvent
2022-02-16PKD change
2021-01-27Name change
2021-01-11Name change
2021-01-11PKD change
2020-04-03Share capital change

FAQ

Last updated: 2026-09-15